Mankind to acquire Bharat Serums for $1.6 billion, including debt
July 25 (Reuters) -
Indian pharmaceutical company Mankind Pharma MNKI.NS said
late on Thursday that it would acquire biopharma firm Bharat
Serums in a deal valued at around 136.30 billion rupees ($1.63
billion), including debt.
($1 = 83.7200 Indian rupees)
(Reporting by Kanjyik Ghosh; Editing by Tasim Zahid)
((Kanjyik.Ghosh@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery